Mollan | Department of Ophthalmology | School of Medicine

Dr. Susan Mollan MBChB, FRCOphth, PhD

Position(s)

Professor

Research Director

SEAMO Chair in Research & Innovation

Contact Info

Tel: 613-544-3400 x 23390 (Kelly Light)

Fax: 613-544-3041

Social Media

ResearchGate link

https://www.researchgate.net/profile/Susan-Mollan

Professor Susan Mollan has an established international reputation in Neuro-ophthalmology. She holds the Southeastern Ontario Academic Medical Organization chair for research and innovation and works as a clinician scientist at Queen’s University. She is also an Honorary Professor at the University of Birmingham, United Kingdom. She is the first international member of the board at the North American Neuro-Ophthalmology Society, and a research theme chair for the European Neuro-Ophthalmology Society.

Her research citizenship includes being an associate editor at Eye Open (Springer); section editor in neuro-ophthalmology for Eye (Springer); section editor in practical neurology (BMJ); sub-editor for original contributions at Journal of Neuro-ophthalmology (Lippincott); and a board member for Neuro-ophthalmology (Taylor and Francis).

Her impactful publications include over 240 peer reviewed articles and 13 book chapters. She reported the first randomized control trial into weight loss methods in idiopathic intracranial hypertension (IIH) (2021). She actively works to provide and pragmatic guidance for clinicians and these include the IIH consensus guidelines (2018); European League Against Rheumatism Giant Cell Arteritis (GCA) guidelines (2019); British Society of Rheumatology GCA guidelines (2020); the European Headache Federation GCA guidelines (2020); the Guidelines of the International Headache Society for Controlled Clinical Trials in IIH (2024). She is currently part of the European Alliance of Association For Rheumatology task force for polymyalgia rheumatica and Large Vessel Vasculitis 2026 guidelines; and a cerebrospinal fluid section panel member delivering the European Association of Neurological Surgeons IIH guidelines for 2027.

Her research interests include clinical trials, raised intracranial pressure, giant cell arteritis, and eye imaging. Her strategic aim is to improve the care of patients with blinding ocular disease in Ontario and beyond, and to inspire the next generation of doctors and clinician scientists.

PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=mollan+s

Google Scholar: https://scholar.google.ca/citations?user=bSW3kVIAAAAJ&hl=en&oi=ao

LinkedIn link

https://www.linkedin.com/in/susie-mollan/

Twitter link

https://bsky.app/profile/drmollan.bsky.social

ResearchGate link

https://www.researchgate.net/profile/Susan-Mollan

Team